BIOVERATIV INC
Summary
Bioverativ is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 8.49 B
Avg. Deal Size£ 4.24 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
